在糖尿病性黄斑水肿的实际治疗中，按结局分层的脉络膜厚度变化。 - Suppr

Suppr

超能文献

Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema.

作者信息

Călugăru Dan, Călugăru Mihai

机构信息

Department of Ophthalmology, University of Medicine Cluj-Napoca/Romania, Cluj-Napoca, Romania.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):241-242. doi: 10.1007/s00417-018-4126-2. Epub 2018 Sep 5.

DOI:10.1007/s00417-018-4126-2

PMID:30187129

Abstract

摘要

相似文献

Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema.在糖尿病性黄斑水肿的实际治疗中，按结局分层的脉络膜厚度变化。

Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):241-242. doi: 10.1007/s00417-018-4126-2. Epub 2018 Sep 5.

The value of choroidal thickness in diabetic macular oedema is contradictory.脉络膜厚度在糖尿病性黄斑水肿中的价值存在矛盾。

Acta Ophthalmol. 2021 Mar;99(2):e281-e282. doi: 10.1111/aos.14529. Epub 2020 Jul 9.

Variation of choroidal thickness in diabetic macular edema: friend or foe?糖尿病性黄斑水肿中脉络膜厚度的变化：是友还是敌？

Acta Ophthalmol. 2021 Mar;99(2):e282-e283. doi: 10.1111/aos.14530. Epub 2020 Jun 26.

CASES IN REFINING MANAGEMENT OF DIABETIC MACULAR EDEMA.糖尿病性黄斑水肿精细化管理病例

Retina. 2018 Nov;38 Suppl 1:1-12. doi: 10.1097/01.iae.0000549839.31969.ee.

Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema.在糖尿病性黄斑水肿的实际治疗中，按结局分层的脉络膜厚度变化

Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1857-1865. doi: 10.1007/s00417-018-4072-z. Epub 2018 Jul 23.

Management of Diabetic Macular Edema.

Ophthalmic Res. 2017;58(1):15-17. doi: 10.1159/000458535. Epub 2017 Mar 14.

Early Response to Ranibizumab Is Associated with 12-Month Outcome in Diabetic Macular Edema after Prior Macular Laser Therapy.雷珠单抗的早期反应与黄斑激光治疗后糖尿病性黄斑水肿12个月的预后相关。

Ophthalmologica. 2017;238(3):139-146. doi: 10.1159/000477627. Epub 2017 Jul 18.

Interdigitation Zone Band Restoration After Treatment of Diabetic Macular Edema.糖尿病性黄斑水肿治疗后指状交叉区带的恢复

Curr Eye Res. 2016 Sep;41(9):1229-34. doi: 10.3109/02713683.2015.1113430. Epub 2016 Feb 1.

Viewing the choroid: where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema.观察脉络膜：我们所处的位置、糖尿病视网膜病变和糖尿病性黄斑水肿中的挑战与矛盾

Acta Ophthalmol. 2017 Aug;95(5):446-459. doi: 10.1111/aos.13210. Epub 2016 Aug 22.

Planned Foveal Detachment Technique for the Resolution of Diabetic Macular Edema Resistant to Anti-Vascular Endothelial Growth Factor Therapy.用于解决抗血管内皮生长因子治疗抵抗的糖尿病性黄斑水肿的计划性黄斑中心凹脱离技术

Retina. 2019 Oct;39 Suppl 1:S162-S168. doi: 10.1097/IAE.0000000000001771.

引用本文的文献

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography.针对未经治疗的 DME 患者的 1 年固定疗程贝伐单抗治疗的反应：OCT 血管造影评估。

J Diabetes Res. 2022 Feb 21;2022:3547461. doi: 10.1155/2022/3547461. eCollection 2022.

Comment on "The thickness and volume of the choroid, outer retinal layers and retinal pigment epithelium layer changes in patients with diabetic retinopathy".关于《糖尿病视网膜病变患者脉络膜、视网膜外层及视网膜色素上皮层的厚度和体积变化》的评论

Int J Ophthalmol. 2019 Aug 18;12(8):1366-1368. doi: 10.18240/ijo.2019.08.23. eCollection 2019.

Romanian ophthalmologists in the renowned ophthalmic journals worldwide.罗马尼亚眼科医生发表于全球知名眼科期刊上的文章。（原英文表述不太完整准确，推测完整意思应该是类似这样，若按照字面翻译是：罗马尼亚眼科医生在全球著名眼科期刊里）

Rom J Ophthalmol. 2018 Oct-Dec;62(4):260-269.

本文引用的文献

Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema.在糖尿病性黄斑水肿的实际治疗中，按结局分层的脉络膜厚度变化

Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1857-1865. doi: 10.1007/s00417-018-4072-z. Epub 2018 Jul 23.

Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success.阿柏西普治疗既往贝伐单抗治疗无效的糖尿病性黄斑水肿：疗效及成功预测因素

Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1353-1354. doi: 10.1007/s00417-018-3951-7. Epub 2018 Mar 9.

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):1035-1037. doi: 10.1007/s00417-018-3901-4. Epub 2018 Jan 20.

Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.糖尿病性黄斑水肿患者玻璃体内注射地塞米松植入剂治疗的早期反应可能预示视力转归。

Am J Ophthalmol. 2018 Feb;186:164-165. doi: 10.1016/j.ajo.2017.10.035. Epub 2017 Dec 6.

Outcomes With As-Needed Aflibercept and Macular Laser Following the Phase III VISTA DME Trial: ENDURANCE 12-Month Extension Study.III期VISTA糖尿病性黄斑水肿试验后按需使用阿柏西普和黄斑激光治疗的结局：耐力12个月延长研究

Am J Ophthalmol. 2017 May;177:235-236. doi: 10.1016/j.ajo.2017.02.025. Epub 2017 Mar 10.

Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting.在英国国家医疗服务体系中，雷珠单抗治疗糖尿病性黄斑水肿的真实世界疗效

Am J Ophthalmol. 2017 Feb;174:175-176. doi: 10.1016/j.ajo.2016.10.013. Epub 2016 Nov 25.

Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.既往抗血管内皮生长因子治疗持续性糖尿病黄斑水肿后改用阿柏西普治疗

Am J Ophthalmol. 2016 Aug;168:290-291. doi: 10.1016/j.ajo.2016.05.015. Epub 2016 Jun 4.

Assessment of choroidal thickness in healthy and glaucomatous eyes using swept source optical coherence tomography.使用扫频源光学相干断层扫描技术评估健康眼和青光眼眼中脉络膜厚度

PLoS One. 2014 Oct 8;9(10):e109683. doi: 10.1371/journal.pone.0109683. eCollection 2014.

Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema.抗血管内皮生长因子疗法对糖尿病性黄斑水肿脉络膜厚度的影响。

Am J Ophthalmol. 2014 Oct;158(4):745-751.e2. doi: 10.1016/j.ajo.2014.06.006. Epub 2014 Jun 19.

Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).高清光谱域光学相干断层扫描（Spectralis）测量黄斑厚度的正常参考值。

Am J Ophthalmol. 2009 Aug;148(2):266-71. doi: 10.1016/j.ajo.2009.03.006. Epub 2009 May 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验